All AbMole products are for research use only, cannot be used for human consumption.
RSV604 (A-60444) is an inhibitor of respiratory syncytial virus (RSV) replication. RSV604 targets the nucleocapsid protein, with a Kd of 1.6 μM. RSV604 displays submicromolar activity against numerous clinical isolates of both the A and B subtypes of RSV (average EC50s=0.8 μM). Although RSV604 displays host-dependent potency against RSV cellular replication (EC50 = 2 μM/HeLa, 1.8 μM/HEp-2, >50 μM/BHK-21 based on cellular viral F protein level 72 hrs post RSV A2 infection) and release (by >1,000,000-fold/HeLa vs. no effect/BHK-21 72 hrs post infection; [RSV604] = EC90), complete loss of infectivity of released RSV from RSV604-treated cells is observed in both HeLa and BHK-21 cultures. RSV604 is also active against bovine RSV, but inactive toward mouse pneumonia virus, human metapneumovirus or parainfluenza virus types 1 &3 (PIV1 &PIV3).
Adv Healthc Mater. 2023 Aug 2;e2301325.
Combination Therapy with Resveratrol and Celastrol Using Folic Acid-Functionalized Exosomes Enhances the Therapeutic Efficacy of Sepsis
RSV604 (A-60444) purchased from AbMole
J Control Release. 2022 Dec 15;353:675-684.
Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia
RSV604 (A-60444) purchased from AbMole
| Molecular Weight | 388.39 |
| Formula | C22H17FN4O2 |
| CAS Number | 676128-63-5 |
| Solubility (25°C) | DMSO 60 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] SreeRupa Challa, et al. Mechanism of action for respiratory syncytial virus inhibitor RSV604
[4] James D Nokes, et al. New strategies for control of respiratory syncytial virus infection
[5] Joanna Chapman, et al. RSV604, a novel inhibitor of respiratory syncytial virus replication
| Related RSV Products |
|---|
| Ribavirin
Ribavirin (ICN-1229) is an antiviral agent used to study severe RSV infections, hepatitis C virus infections, and other viral infections. |
| Presatovir
Presatovir is a novel, orally bioavailable RSV fusion inhibitor, against a wide range of RSV A and B clinical isolates (mean EC50 = 0.43 nM). |
| VV116 hydrobromide
VV116 (JT001) hydrobromide is an orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV) infection. |
| Palivizumab
Palivizumab (MEDI 493) is a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection. |
| Nirsevimab
Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
